SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.
CIK 1392309 · last filed 2019-03-06
SV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider sold $7.0M of KALV on Mar 6, 2019. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
2
-$6.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. (KALV) Delisted | 10%+ Owner | 2,191,576 | $27.00 | $59.17M | -$6.95M | 1 | 2019-03-06 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 11,406,831 | — | — | $0 | 1 | 2013-10-02 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-06 | KalVista Pharmaceuticals, Inc. (KALV) Delisted | Sell (S) | −302,840 | -$6.95M | EDGAR |
| 2013-10-02 | IVERIC bio, Inc. (OPHT) Delisted | Conv (C) | +69,398,928 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.